Project Grant R01AI177540
Award Date
1/17/25
Completion Date
12/31/29
Dollars Obligated
$513K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Iowa, USA
Similar Awards
This Project Grant awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) provides $648,924 from February 2025 to January 2030 to Iowa State University of Science and Technology to conduct research on the role of mosquito extracellular vesicles in malaria parasite killing and immune priming. The key research aims are to define the mechanisms by which mosquito extracellular vesicles (EVs) promote...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $211,038 Project Grant (CFDA 93.855 Allergy and Infectious Diseases Research) to The Johns Hopkins University to conduct research on targeting a reductive dehalogenase enzyme as a new strategy for controlling mosquito populations. The research aims to explore how inhibiting this enzyme or accumulating certain halotyrosines can negatively impact mosquito fertility, providing a novel approach to mitigating vector-borne...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $783,961.00 to support research investigating the mechanisms underlying mosquito infectiousness in malaria. The primary awardee, The Johns Hopkins University, will conduct experiments to determine the inocula associated with low- and high-infected mosquitoes using both rodent malaria parasites and the human parasite P....
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $707,696 federal Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Johns Hopkins University. The grant supports research to identify volatile organic compounds in human scent signatures that influence the attractiveness of humans to the African malaria mosquito Anopheles gambiae, a major disease vector. The project aims to characterize the contribution of the human skin...
This $1,845,103 Project Grant award, funded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to identify surface-exposed proteins on early mosquito-stage Plasmodium falciparum parasites. The goal is to accelerate the discovery of transmission-blocking vaccine candidates that can prevent malaria transmission from humans to mosquitoes. The key activities include using mass...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $760,318 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of California, Davis. The grant supports the development and testing of "Recombinant Enhanced Antiviral Sensors" (REAVRS) - novel proteins that combine virus-sensing and antiviral effector domains to broadly inhibit a range of viruses, including those transmitted by mosquitoes. The research aims...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) provides $699,814 to Florida International University to study malaria transmission between mosquitoes and humans. The key objectives are to: 1) characterize proteins from the malaria parasite and mosquito midgut that mediate parasite invasion, 2) develop monoclonal antibodies targeting these proteins, and 3) design...
This $153,512 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to understand and overcome immune evasion mechanisms used by Plasmodium parasites, the causative agents of malaria. The research aims to characterize the memory B cell response to the circumsporozoite protein (CSP) antigen, which is the target of currently deployed malaria vaccines, in order to identify...
This Cooperative Agreement award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $606,815 to Duquesne University to engineer paratransgenic bacterial strains that can interfere with the ability of mosquitoes to transmit malaria parasites. The key objectives are to: 1) Create paratransgenic strains of Asaia bogorensis bacteria that are suitable for field release, with no antibiotic...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) provides $298,350 to Iowa State University of Science and Technology to define the virosphere of understudied hematophagous (blood-feeding) arthropods and identify novel viruses capable of vertebrate cell replication. The key objectives are to: 1) screen a collection of over 37,000 arthropod samples from North America for...